Ben Blue

Ora Biomedical closes funding on mTOR screening project Rapamycin Longevity Labs and Ora Biomedical have officially reached the funding goal for the largest-ever lifespan analysis of 601 mTOR modulators! This project is driven by Rapamycin  The mission is to identify compounds even more potent than Rapamycin in extending lifespan in model animals. 

Ben Blue PhD featured on NUS Healthy Longevity lecture series https://www.youtube.com/watch?v=BWpAlCiCH9c&t=2s Ora co-founders Brian Kennedy and Ben Blue discuss Ora’s ongoing work.  

Ora CEO Dr. Ben Blue featured on Siim Land’s hit podcast https://www.youtube.com/watch?v=A1pFLecoHCM&t=2s Dr. Blue chats with anthropologist Siim Land about Ora Biomedical’s mission to develop novel therapeutics that target the molecular biology of aging.